↓ Skip to main content

Engineering and Application of Pluripotent Stem Cells

Overview of attention for book
Attention for Chapter 23: Requirements for Using iPSC-Based Cell Models for Assay Development in Drug Discovery
Altmetric Badge

Citations

dimensions_citation
1 Dimensions

Readers on

mendeley
12 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Chapter title
Requirements for Using iPSC-Based Cell Models for Assay Development in Drug Discovery
Chapter number 23
Book title
Engineering and Application of Pluripotent Stem Cells
Published in
Advances in biochemical engineering biotechnology, January 2017
DOI 10.1007/10_2017_23
Pubmed ID
Book ISBNs
978-3-31-973590-0, 978-3-31-973591-7
Authors

Klaus Christensen, Filip Roudnicky, Christoph Patsch, Mark Burcin

Abstract

A prevalent challenge in drug discovery is the translation of findings from preclinical research into clinical success. Currently, more physiological in vitro systems are being developed to overcome some of these challenges. In particular, induced pluripotent stem cells (iPSCs) have provided the opportunity to generate human cell types that can be utilized for developing more disease-relevant cellular assay models. As the use of these complex models is lengthy and fairly complicated, we lay out our experiences of the cultivation, differentiation, and quality control requirements to successfully utilize pluripotent stem cells in drug discovery.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 12 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 12 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 3 25%
Student > Bachelor 1 8%
Student > Doctoral Student 1 8%
Researcher 1 8%
Student > Postgraduate 1 8%
Other 0 0%
Unknown 5 42%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 5 42%
Pharmacology, Toxicology and Pharmaceutical Science 1 8%
Agricultural and Biological Sciences 1 8%
Neuroscience 1 8%
Unknown 4 33%